WallStSmart

Turtle Beach Corporation (TBCH)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Turtle Beach Corporation generates 37% more annual revenue ($319.91M vs $233.27M). TBCH leads profitability with a 4.9% profit margin vs -28.3%. TBCH earns a higher WallStSmart Score of 53/100 (C-).

TBCH

Buy

53

out of 100

Grade: C-

Growth: 4.0Profit: 6.0Value: 7.3Quality: 6.0
Piotroski: 2/9Altman Z: 1.40

ZEPP

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

TBCHSignificantly Overvalued (-92.1%)

Margin of Safety

-92.1%

Fair Value

$6.05

Current Price

$11.23

$5.18 premium

UndervaluedFair: $6.05Overvalued

Intrinsic value data unavailable for ZEPP.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

TBCH3 strengths · Avg: 8.0/10
PEG RatioValuation
0.908/10

Growing faster than its price suggests

P/E RatioValuation
14.3x8/10

Attractively priced relative to earnings

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
78.5%10/10

Revenue surging 78.5% year-over-year

Areas to Watch

TBCH4 concerns · Avg: 2.8/10
Market CapQuality
$251.94M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
4.9%3/10

4.9% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Revenue GrowthGrowth
-18.7%2/10

Revenue declined 18.7%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$237.22M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-24.4%2/10

ROE of -24.4% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-28.3%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : TBCH

The strongest argument for TBCH centers on PEG Ratio, P/E Ratio, Price/Book. PEG of 0.90 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 78.5% demonstrates continued momentum.

Bear Case : TBCH

The primary concerns for TBCH are Market Cap, Profit Margin, Piotroski F-Score. Thin 4.9% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

TBCH profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

TBCH carries more volatility with a beta of 2.27 — expect wider price swings.

ZEPP is growing revenue faster at 78.5% — sustainability is the question.

Monitor CONSUMER ELECTRONICS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TBCH scores higher overall (53/100 vs 38/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Turtle Beach Corporation

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Turtle Beach Corporation is an audio technology company in North America, Europe, the Middle East, and the Asia Pacific. The company is headquartered in White Plains, New York.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?